PMDA drug package insert
サラジェン錠5mg
PMDA Prescription drug · キッセイ薬品工業株式会社 · package insert Jun 28, 2023
Key facts
| Brand names | サラジェン錠5mg |
|---|---|
| Nonproprietary names | ピロカルピン塩酸塩 |
| Companies | 製造販売元／キッセイ薬品工業株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 口腔乾燥症状改善薬 |
| Therapeutic category codes | 87239 |
| YJ codes | 2399013F1021 |
| Approval numbers | 21700AMY00220000 |
| Package insert edition | 第1版 |
| Package insert date | Jun 28, 2023 |
| PMDA document key | 230034_2399013F1021_1 |
| PMDA company code | 230034 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: